SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209 | -100.0% | 231,417 | -16.2% | 0.00% | -100.0% |
| Q3 2022 | $1,658,000 | +69.4% | 276,266 | +16.8% | 0.00% | – |
| Q2 2022 | $979,000 | +17.2% | 236,535 | +7.6% | 0.00% | – |
| Q1 2022 | $835,000 | -8.4% | 219,864 | +8.5% | 0.00% | – |
| Q4 2021 | $912,000 | -15.9% | 202,684 | -12.9% | 0.00% | – |
| Q3 2021 | $1,085,000 | -13.5% | 232,763 | +30.8% | 0.00% | – |
| Q2 2021 | $1,255,000 | +306.1% | 177,998 | +240.6% | 0.00% | – |
| Q1 2021 | $309,000 | – | 52,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
| NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
| Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
| RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
| Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
| Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
| SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
| EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
| TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
| Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |